You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Keytruda

Showing 26 - 50 of 945
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Trial (Pembrolizumab)

Recruiting
  • Colorectal Cancer
  • Amsterdam, Netherlands
    Netherlands Cancer Institute
Jan 3, 2023

HNSCC Trial (Danvatirsen, Pembrolizumab)

Not yet recruiting
  • HNSCC
  • (no location specified)
Apr 3, 2023

Head and Neck Squamous Cell Cancer Trial (pembrolizumab, methotrexate, docetaxel)

Completed
Has Results
  • Head and Neck Squamous Cell Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 24, 2022

Metastatic Solid Tumors, Advanced Solid Tumors Trial (MK-0472, Pembrolizumab)

Not yet recruiting
  • Metastatic Solid Tumors
  • Advanced Solid Tumors
  • (no location specified)
May 2, 2023

Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • (no location specified)
Oct 5, 2023

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Trial in Pittsburgh (Pembrolizumab, Carboplatin,

Not yet recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 18, 2023

Bladder Cancer Trial in Chapel Hill, Durham (pembrolizumab, gemcitabine and cisplatin)

Active, not recruiting
Has Results
  • Bladder Cancer
  • pembrolizumab, gemcitabine and cisplatin
  • Chapel Hill, North Carolina
  • +1 more
Oct 11, 2022

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Solid Tumor, Cutaneous Squamous Cell Carcinoma, Endometrial Cancer Trial (favezelimab/pembrolizumab, pembrolizumab, lenvatinib)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • favezelimab/pembrolizumab
  • +2 more
  • (no location specified)
Sep 7, 2023

NSCLC, Melanoma Trial (IMM60, Pembrolizumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Melanoma
  • (no location specified)
Jan 24, 2023

MSI-H Colorectal Cancer Trial in Pittsburgh (Regorafenib, Pembrolizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 17, 2023

Breast Cancer Trial in Boston (Pembrolizumab, Nab-Paclitaxel, Biopsy)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 22, 2022

Renal Cell Carcinoma Trial in Philadelphia (Pembrolizumab infusion, Lenvatinib tablet)

Not yet recruiting
  • Renal Cell Carcinoma
  • Pembrolizumab infusion
  • Lenvatinib tablet
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Feb 8, 2023

Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab injection
  • +2 more
  • (no location specified)
Jul 25, 2023

Solid Tumor Trial (SKB264, Pembrolizumab)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Dec 8, 2022

Breast Cancer Trial in Los Angeles (Pembrolizumab, RT Boost)

Active, not recruiting
  • Breast Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 1, 2022

Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Pembrolizumab 25 mg/ml
  • Paclitaxel injection
  • (no location specified)
Oct 11, 2023

Metastatic Colorectal Cancer Trial in Køge (Irreversible electroporation, Calcium electroporation, Pembrolizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Irreversible electroporation
  • +2 more
  • Køge, Denmark
    Zealand University Hospital
Jan 27, 2023

Melanoma Trial in Norway (BGB324+pembrolizumab, BGB324+dabrafenib and trametinib, pembrolizumab)

Active, not recruiting
  • Melanoma
  • Bergen, Norway
  • +4 more
Aug 24, 2022

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Locally Advanced Esophageal and Gastric Cancers (EGC) Trial in Durham (Pembrolizumab)

Active, not recruiting
  • Locally Advanced Esophageal and Gastric Cancers (EGC)
  • Durham, North Carolina
    Duke Cancer Center
Dec 7, 2022

Urothelial Carcinoma Trial in New York (Naptumomab Estafenatox, Pembrolizumab, Obinutuzumab)

Not yet recruiting
  • Urothelial Carcinoma
  • Naptumomab Estafenatox
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
May 30, 2023

Solid Tumors Trial in Charlottesville (XmAb662, Keytruda® (pembrolizumab))

Recruiting
  • Solid Tumors
  • XmAb662
  • Keytruda® (pembrolizumab)
  • Charlottesville, Virginia
    University Of Virginia Comprehensive Cancer Center
Aug 10, 2023

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy Trial (neoadjuvant anti-PD-1 (Keytruda) plus chemo)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Chemoimmunotherapy
  • neoadjuvant anti-PD-1 (Keytruda) plus chemotherapy
  • (no location specified)
Feb 14, 2023

Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

Not yet recruiting
  • Renal Cancer
  • +3 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jul 24, 2023